Cutaneous Lymphoma and Disorders of Systemic Disease: Updates and Potential Gaps

Conclusions

• There is a significant practice gap in the understanding and classification of various cutaneous lymphomas, particularly mycosis fungoides and its variants, necessitating ongoing education for clinicians.
• Mycosis fungoides has multiple subtypes, each with differing prognoses, highlighting the importance of accurate diagnosis.
• Folliculotropic mycosis fungoides may present with a good prognosis in early stages but can also exhibit aggressive behavior in advanced stages.
• Hyperpigmented variants of mycosis fungoides can mimic other conditions like lichen planus pigmentosus, emphasizing the need for careful histopathological evaluation.
• Interstitial mycosis fungoides is an underrecognized variant that can coexist with granulomatous features and should be included in differential diagnoses.
• Pediatric cutaneous lymphomas, such as follicular mucinosis, often have favorable outcomes, indicating the potential for conservative management.
• COVID-19 vaccinations have been associated with cutaneous lymphoproliferative disorders mimicking lymphomatoid papulosis, underscoring the importance of awareness among healthcare providers.
• New insights into classifications of cutaneous lymphomas, including the WHO-EORTC updates, show evolving criteria that must be recognized by practicing clinicians to ensure appropriate management.
• IgG4-related skin diseases may present with features similar to other conditions, necessitating specific diagnostic approaches to improve accuracy.
• The relationship between gamma delta T cell lymphomas and mycosis fungoides suggests that additional studies are required to clarify their classification and clinical implications.